Page 349 - Vitamin D and Cancer
P. 349

336                                                       B.W. Hollis

              3.  Houghton LA, Vieth R (2006) The case against ergocalciferol (vitamin D ) as a vitamin sup-
                                                                 2
               plement. Am J Clin Nutr 84:694–697
              4.  Aramas  LA,  Hollis  BW,  Heaney  RP  (2004)  Vitamin  D   is  much  less  than  vitamin  D   in
                                                                            3
                                                      2
               humans. J Clin Endocrinol Metab 89:5387–5391
              5.  Holick MF, Biancusso RM, Chen TC et al (2008) Vitamin D  is as effective as vitamin D  in
                                                                            3
                                                        2
               maintaining  circulating  concentrations  of  25-hydroxyvitamin  D.  J  Clin  Endocrinol  Metab
               93:677–681
              6.  Bouillon R, Okamura WH, Norman AW (1995) Structure-function relationships in the vitamin D
               endocrine system. Endocrine Rev 16:200–257
              7.  Hollis BW (2005) Detection of vitamin D and its major metabolites. In: Feldman D, Pike J,
               Glorieux F (eds) Vitamin D, 2nd edn. Elsevier, San Diego, CA
              8.  Bouillion R, Auwerx J, Dekeyser et al (1984) Two direct (nonchromatographic) assays for
               25-hydroxyvitamin D. Clin Chem 30:1731–1736
              9.  Belsey R, DeLuca HF, Potts JT (1974) A rapid assay 25-OH-vitamin D  without preparative
                                                                3
               chromatography. J Clin Endocrinol Metab 38:1046–1051
              10. Dorantes LM, Arnaud SB, Arnaud CD (1978) Importance of the isolation of 25-hydroxyvitamin
               D before assay. J Lab Clin Med 91:791–796
              11. Leventis HC, Garrison L, Sibley M et al (2005) Underestimation of serum 25-hydroxyvitamin
               D by the Nichols Advantage Assay in patients receiving vitamin D  replacement therapy. Clin
                                                            2
               Chem 51:1072–1074
              12. Carter  GD,  Jones  JC,  Berry  JL  (2007)  The  anomalous  behaviour  of  exogenous
               25-hydroxyvitamin D in competitive binding assays. J Steroid Biochem Mol Biol 103:480–482
             13.  Hollis BW, Napoli JL (1985) Improved radioimmunoassay for vitamin D and its use in assessing
               vitamin D status. Clin Chem 31:1815–1819
              14. Hollis BW,  Kamerud  JQ,  Selvaag  SR  et al  (1993)  Determination of vitamin  D  status by
               radioimmunoassay with an  I-labeled tracer. Clin Chem 39:529–533
                                  125
              15. Ersfeld DL, Rao DS, Body JJ et al (2004) Analytical and clinical validation of the 25 OH
               vitamin D assay for the LIAISON automated analyzer. Clin Biochem 37:867–874
              16. Lensmeyer  GL,  Wiebe  DA,  Binkley  N,  Drezner  MK  (2006)  HPLC  measurement  for
               25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin Chem 52:
               1120–1126
              17. Singh RJ, Taylor RL, Reddy GS, Grebe SK (2006) C-3 epimers can account for asignificant
               proportion of total circulating 25(OH)D in infants, complicating accurate measurement and
               interpretation of vitamin D status. J Clin Endocrinol Metab 91:3055–3061
              18.  Maunsell Z, Wright DJ, Rainbow SJ (2005) Routine Isotope-dilution liquid chromatography-
               tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites
               of vitamins D  and D . Clin Chem 51:1683–1690
                        2
                             3
              19. Chen  H,  McCoy  LF,  Schleicher  RL,  Pfeiffer  CM  (2008)  Measurement  of  25(OH)D   and
                                                                          2
               25(OH)D  in human serum using liquid chromatography-tandem mass spectrometry and it
                     3
               comparisons to a radioimmunoassay method. Clin Chem Acta 391:6–12
              20. Saenger AK, Laha TJ, De B, Sadzadeh MH (2006) Quantification of serum 25-hydroxyvita-
               min D  and D  using HPLC-tandem mass spectrometry and examination of reference intervals
                   2
                        3
               for diagnosis of vitamin D deficiency. Am J Clin Pathol 125:914–920
              21. Binkley N, Drezner MK, Hollis BW (2006) Laboratory reporting of 25-hydroxyvitamin D
               results: potential for clinical misinterpretation. Clin Chem 52:2124–2125
              22. Gloth FM, Gundberg CM, Hollis BW et al (1995) Vitamin D deficiency in homebound elderly
               persons. JAMA 274:1683–1686
             23.  Vieth R, Ladaky WPG (2003) Age-related changes in the 25(OH)D versus parathyroid hormone
               relationship  suggest  a  different  reason  why  older  adults  require  more  vitamin  D.  J  Clin
               Endocrinol Metab 88:185–191
              24. Heaney RP, Dowell MS, Hale CA, Bendich A (2003) Calcium absorption varies within the
               reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 22:142–146
              25. Looker AC, Mussolino ME (2008) Serum 25-hydroxyvitamin D and hip fracture risk in older
               white adults. J Bone Min Res 23:143–150
   344   345   346   347   348   349   350   351   352   353   354